Google Life Sciences and the American Heart Association team up on new research venture

Google Life Sciences (GLS) and the American Heart Association (AHA) has announced a $50 million collaboration to find new ways to fight heart disease.

GLS  and AHA have agreed to invest $25 million each for a total of $50 million over roughly five years to fund research in coronary heart disease, which causes one in every three deaths in the United States.

Heart disease is the world's top killer, a problem that "seems ripe for new innovation" and disruptive, unconventional thinking, said Andy Conrad, Google Life Sciences' chief executive. Progress has been slow and "we should shake it up a little bit," he said.

What is surprising about the collaboration is how the money will be distributed: all $50 million will go to one interdisciplinary team led by one investigator.

This marks the largest one-time research investment in AHA’s history. For the Google group, its latest biomedical venture will join projects that include innovative devices such as driverless cars, contact lenses that monitor blood-sugar for diabetics and health-tracking wristbands.

The official announcement can be found here.

Date: 07/12/2015 | Tag: | News: 434 of 1588
All news


More news


More events

Subscribe to the VPH Institute Newsletter


Read all the newsletters of the VPH Institute